Who is sponsoring NCT04927364?

NCT04927364 is sponsored by VA Palo Alto Health Care System.

What drugs are being tested in NCT04927364?

Interventions in NCT04927364: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil.

What condition does NCT04927364 study?

NCT04927364 studies Alcohol Use Disorder (AUD), Transcranial Magnetic Stimulation.

Is NCT04927364 still recruiting?

NCT04927364 is currently completed. Last updated 29 December 2025.

Are results published for NCT04927364?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-12-29 · How we verify

NCT04927364

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder

Completed NA Results posted Last updated 29 December 2025

What this trial tests

NA trial testing Deep Transcranial Magnetic Stimulation (dTMS) H7 coil in Alcohol Use Disorder (AUD) in 8 participants. Completed in 17 November 2023.

Timeline

6 September 2022

Primary endpoint
17 November 2023

17 November 2023

Quick facts

Lead sponsor	VA Palo Alto Health Care System
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	8
Start date	6 September 2022
Primary completion	17 November 2023
Estimated completion	17 November 2023
Sites	1 location across United States

Drugs / interventions tested

Deep Transcranial Magnetic Stimulation (dTMS) H7 coil

Conditions studied

Alcohol Use Disorder (AUD) — all drugs for Alcohol Use Disorder (AUD) →
Transcranial Magnetic Stimulation — all drugs for Transcranial Magnetic Stimulation →

Sponsor

VA Palo Alto Health Care System

Who can join

Adults 21 to 70, any sex, with Alcohol Use Disorder (AUD) or Transcranial Magnetic Stimulation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Relapse to Alcohol 6 Months After Treatment Primary · 6 months

Six months after completing the intervention, participants will be contacted to determine self-reported relapse status. To determine relapse status, participants complete brief standardized measures of alcohol and substance use, Alcohol Timeline Followback (TLFB) and the Brief Addiction Monitor (BAM) questionnaire.

Group	Value	95% CI
Active dTMS	3

Percentage of Days Abstinent Primary · 6 months

Abstinence defined as no drinks consumed.

Group	Value	95% CI
Active dTMS	85.1	± 32.06

Percentage of Days of Heavy Drinking Primary · 6 months

Heavy drinking is defined as consuming (in a 24 hour period) 3 or more drinks for women, or 4 or more drinks for men.

Group	Value	95% CI
Active dTMS	2.7	± 5.37

Sponsor's own description

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with an alcohol use disorder (AUD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alcohol Use Disorder (AUD)

Currently open trials in the same condition.

NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
NCT07040592 — Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide · Phase 2 · recruiting
NCT06949423 — Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder · NA · recruiting
NCT06070649 — The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) · Phase 1 · recruiting
NCT06335407 — Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study · Phase 1 · recruiting

Other VA Palo Alto Health Care System trials

Trials by the same sponsor.

NCT06140706 — Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI · NA · not yet recruiting
NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
NCT07083869 — Testing the Insomnia Coach Mobile App With Veterans With Insomnia and PTSD · NA · not yet recruiting
NCT06646614 — Group Advanced Care Planning Pilot for Veterans · NA · recruiting
NCT06027944 — Impact of Light on Mood · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04927364 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Palo Alto Health Care System
Last refreshed: 29 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04927364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing